QBC Diagnostics was awarded one of the largest contracts in company history, as the United States Navy has agreed to install QBC STAR hematology analyzers on surface ships throughout the world. The QBC STAR provides users a 9-parameter complete blood count through its patented dry hematology approach, which eliminates the need for liquid reagents…
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market a new software release for its Autopheresis-C® system. Blood and plasma centers worldwide use the Autopheresis-C system to collect plasma from donors…
ICU Medical, Inc. (Nasdaq: ICUI), a worldwide leader in the development, manufacture and sale of proprietary, disposable medical connection systems for use in vascular therapy applications, confirmed that it has received FDA 510-k clearance for the Neutron™ Neutral-Pressure Needleless Connector…
AdvanDx announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its Yeast Traffic Light® PNA FISH® test. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes…
Roche Diagnostics announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the CoaguChek® XS Pro system, a new point-of-care anticoagulation monitor with a built-in bar code reader that can automatically scan and capture operator and patient identification information…
Scientists are reporting development of the first “dipstick” test for instantly determining a person’s blood type at a cost of just a few pennies. Their study on the test, which involves placing a drop of blood on a specially treated paper strip, appears in ACS’ semi-monthly journal Analytical Chemistry, where the authors say it could be a boon to health care in developing countries…
CoaguSense™, Inc., a diagnostic device company that has been in stealth mode for the past two years, today unveiled the first portable point-of-care Prothrombin Time/International Normalized Ratio (PT/INR) analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications such as Coumadin® or warfarin…
Emerging Healthcare Solutions, Inc. (Pink Sheets:EHSI) announced that the Company is adding a module to incorporate at home diagnosis and monitoring of various blood disorders as options to its new breakthrough medical iPhone app, currently in development…
Promega Corporation now offers the Maxwell® 16 LEV Blood DNA Kit which is designed to purify DNA from whole blood. The new kit, optimized to work on the Maxwell® 16 instrument, eliminates the need for a buffy coat step while providing exponentially higher concentration in less time with parallel purity…
A mobile compression device is as effective as medication at preventing the formation of blood clots after hip replacement surgery but provides greater patient safety, according to a study in the March issue of the Journal of Bone & Joint Surgery. “This device is as useful as blood thinners for the reduction of blood clots after hip replacement and it’s superior in safety,” said Douglas E…